Transcription So my name is Virginie Hivert, I’m working for EURORDIS, the European organisation for rare disease patients. I’m the Therapeutic Development Director, and so I’m a patient...
Transcription My name is Dániel Végh. I’m coming from Hungary and I’m here to represent patients with diabetes from Hungary, but also Europe and global. My role is...
Life-cycle management activities begin as soon as a medicine receives authorisation from the regulatory authorities. Research on the medicine continues in order to gather additional data on safety and...
Some groups within the general population of a clinical study may require special study, due to the particular risks, benefits, or treatment requirements associated with them
Patient advocates can be involved in early clinical development through partnerships and working relationships with regulatory authorities, ethics committees, investigators, and industry. They can provide input and play an...
An example of patients involved through patients and patient organisations providing input into a
Cushing’s disease clinical trial design. The consultation took place between Novartis and nurses from different teams...
Introduction A collaboration of the Patient Consumer Group [part of National Research Institute for Health Research (NIHR), Clinical Research Network] with the pharmaceutical company Eli Lilly. Where in the...
Introduction A case report on Phase I patient involvement into study design through interviews where they share their views on the disease and the cutaneous symptoms. The information that...